IL37 and precursor B-cell acute lymphoblastic leukemia: Overall, the results of our study demonstrate that IL‐37 can rejuvenate the function of aged endogenous T‐cells and boost the efficacy of aged CAR T‐cells resulting in attenuated B‐ALL pathogenesis.